Show simple item record

dc.contributor.authorBernatsky, S
dc.contributor.authorRamsey-Goldman, R
dc.contributor.authorRajan, R
dc.contributor.authorBoivin, J-F
dc.contributor.authorJoseph, L
dc.contributor.authorLachance, S
dc.contributor.authorCournoyer, D
dc.contributor.authorZoma, A
dc.contributor.authorManzi, S
dc.contributor.authorGinzler, E
dc.contributor.authorUrowitz, M
dc.contributor.authorGladman, D
dc.contributor.authorFortin, P R
dc.contributor.authorEdworthy, S
dc.contributor.authorBarr, S
dc.contributor.authorGordon, C
dc.contributor.authorBae, S-C
dc.contributor.authorSibley, J
dc.contributor.authorSteinsson, K
dc.contributor.authorNived, O
dc.contributor.authorSturfelt, G
dc.contributor.authorSt Pierre, Y
dc.contributor.authorClarke, A
dc.date.accessioned2023-02-03T17:29:22Z
dc.date.available2023-02-03T17:29:22Z
dc.identifier.citationBernatsky S, Ramsey-Goldman R, Rajan R, Boivin JF, Joseph L, Lachance S, Cournoyer D, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Steinsson K, Nived O, Sturfelt G, St Pierre Y, Clarke A. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis. 2005 Oct;64(10):1507-9. doi: 10.1136/ard.2004.034504. PMID: 16162903; PMCID: PMC1755239.en_US
dc.identifier.issn0003-4967
dc.identifier.pmid16162903
dc.identifier.urihttp://hdl.handle.net/20.500.12648/8231
dc.description.abstractRecent evidence supports an association between systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
dc.description.abstractTo describe demographic factors, subtypes, and survival of patients with SLE who develop NHL.
dc.description.abstractA multi-site cohort of 9547 subjects with definite SLE was assembled. Subjects at each centre were linked to regional tumour registries to determine cancer cases occurring after SLE diagnosis. For the NHL cases ascertained, descriptive statistics were calculated, and NHL subtype frequency and median survival time of patients determined.
dc.description.abstract42 cases of NHL occurred in the patients with SLE during the 76,948 patient-years of observation. The median age of patients at NHL diagnosis was 57 years. Thirty six (86%) of the 42 patients developing NHL were women, reflecting the female predominance of the cohort. In the patients, aggressive histological subtypes appeared to predominate, with the most commonly identified NHL subtype being diffuse large B cell (11 out of 21 cases for which histological subtype was available). Twenty two of the patients had died a median of 1.2 years after lymphoma diagnosis.
dc.description.abstractThese data suggest aggressive disease in patients with SLE who develop NHL. Continuing work should provide further insight into the patterns of presentation, prognosis, and aetiology of NHL in SLE.
dc.language.isoenen_US
dc.relation.urlhttps://ard.bmj.com/content/64/10/1507.longen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleNon-Hodgkin's lymphoma in systemic lupus erythematosus.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleAnnals of the rheumatic diseasesen_US
dc.source.volume64
dc.source.issue10
dc.source.beginpage1507
dc.source.endpage9
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryEngland
dc.description.versionVoRen_US
refterms.dateFOA2023-02-03T17:29:22Z
html.description.abstractRecent evidence supports an association between systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
html.description.abstractTo describe demographic factors, subtypes, and survival of patients with SLE who develop NHL.
html.description.abstractA multi-site cohort of 9547 subjects with definite SLE was assembled. Subjects at each centre were linked to regional tumour registries to determine cancer cases occurring after SLE diagnosis. For the NHL cases ascertained, descriptive statistics were calculated, and NHL subtype frequency and median survival time of patients determined.
html.description.abstract42 cases of NHL occurred in the patients with SLE during the 76,948 patient-years of observation. The median age of patients at NHL diagnosis was 57 years. Thirty six (86%) of the 42 patients developing NHL were women, reflecting the female predominance of the cohort. In the patients, aggressive histological subtypes appeared to predominate, with the most commonly identified NHL subtype being diffuse large B cell (11 out of 21 cases for which histological subtype was available). Twenty two of the patients had died a median of 1.2 years after lymphoma diagnosis.
html.description.abstractThese data suggest aggressive disease in patients with SLE who develop NHL. Continuing work should provide further insight into the patterns of presentation, prognosis, and aetiology of NHL in SLE.
dc.description.institutionSUNY Downstateen_US
dc.description.departmentRheumatologyen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalAnnals of the rheumatic diseases


Files in this item

Thumbnail
Name:
1507.full.pdf
Size:
57.81Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International